Literature DB >> 25158264

Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal squamous cell carcinoma.

Y M Hong1, W G Gan2, Z H Xu3.   

Abstract

This study aimed to determine the expression of integrin β1 and vascular endothelial growth factor (VEGF) and microvascular density (MVD) by CD105 staining in hypopharyngeal squamous cell carcinoma to determine their association with clinicopathologic characteristics, and to determine their role and the effects of their interactions in the development and progression of hypopharyngeal squamous cell carcinomas. The expression of integrin β1 and VEGF and MVD in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal tissues were evaluated using immunohistochemistry. The Image-Pro Plus software was used to determine the mean optical density of the immunohistochemical images. Integrin β1 expression was significantly higher in hypopharyngeal squamous cell carcinoma tissues (78.00%) than in normal hypopharyngeal tissues (35.00%; P = 0.001) and significantly differed across pathologic grades and different T stages, and regarding the presence of cervical lymph node metastasis (P < 0.05). VEGF expression was significantly higher in hypopharyngeal squamous cell carcinoma tissues (74.00%) than in normal hypopharyngeal tissues (30.00%; P = 0.002), VEGF overexpression differed significantly across different pathologic grades and different T stages, and regarding the presence of cervical lymph node metastasis (P < 0.05). The MVD count was significantly higher in hypopharyngeal squamous cell carcinoma tissues (37.10 ± 5.95) than in normal hypopharyngeal tissues (8.70 ± 3.34; P = 0.000). MVD differed significantly across different pathologic grades and different T stages, and regarding the presence of cervical lymph node metastasis (P < 0.05). The expression of integrin β1 and VEGF and the MVD count exhibited no significant differences in terms of age, gender, history of smoking, and clinical stages (P > 0.05). VEGF expression was positively associated with the MVD count of hypopharyngeal squamous cell carcinomas (r = 0.582, P = 0.000); however, integrin β1 was not associated with VEGF or MVD (P > 0.05). Integrin β1 and VEGF are overexpressed and MVD increased in hypopharyngeal squamous cell carcinomas. VEGF is positively correlated with MVD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25158264     DOI: 10.4238/2014.August.25.9

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

Review 1.  β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

Authors:  Boju Pan; Junchao Guo; Quan Liao; Yupei Zhao
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

2.  Dietary Restriction Affects Neuronal Response Property and GABA Synthesis in the Primary Visual Cortex.

Authors:  Jinfang Yang; Qian Wang; Fenfen He; Yanxia Ding; Qingyan Sun; Tianmiao Hua; Minmin Xi
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

3.  Non-tight junction-related function of claudin-7 in interacting with integrinβ1 to suppress colorectal cancer cell proliferation and migration.

Authors:  Wenjing Li; Chang Xu; Kun Wang; Yuhan Ding; Lei Ding
Journal:  Cancer Manag Res       Date:  2019-02-13       Impact factor: 3.989

Review 4.  Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.

Authors:  Ping-Hsiu Wu; Abayomi Emmanuel Opadele; Yasuhito Onodera; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

5.  Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.

Authors:  Jinyun Tan; Xijun Sun; Shaoyu Wang; Baoqin Ma; Zhaohui Chen; Yaowei Shi; Li Zhang; Mohd Asif Shah
Journal:  J Healthc Eng       Date:  2021-10-11       Impact factor: 2.682

6.  Downregulation of RNA binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma FaDu cells.

Authors:  Yuefeng Han; Mingjie Zhang; Deshang Chen; Hui Li; Xiaomin Wang; Shiyin Ma
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.